Iovance Biotherapeutics Inc

Financials

Flujo de caja de las actividades operativas -205.13 M-227.94 M-292.76 M-361.82 M-352.98 M-302.41 M -302.41 M Flujo de caja de las actividades de inversión -317.85 M132 K256.45 M-155.24 M-96.41 M47.5 M 47.5 M Flujo de caja de las actividades financieras 576.42 M239.27 M190.15 M462.96 M390.66 M300.77 M 300.77 M Flujo de caja libre -251.93 M-265.51 M-313.18 M-384.11 M-364.05 M-336.24 M -336.24 M

Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer.

IOVA

Financials

Iovance Biotherapeutics Inc

Noticias

Undercovered Stocks: Zscaler, Aeluma, Devon Energy, And More

Jefferies reitera calificación de compra para acciones de Iovance Biotherapeutics

Iovance Biotherapeutics: Positioned For Multi-Year Growth, Buy The Pullback (NASDAQ:IOVA)

Iovance Biotherapeutics: Competition Afoot, But New Indications Can Help (NASDAQ:IOVA)

Iovance Biotherapeutics (IOVA) Down 2.1% Since Last Earnings Report: Can It Rebound?

Eton Pharmaceuticals (ETON) Soars 6.7%: Is Further Upside Left in the Stock?

Wendy Yarno, miembro de la junta de Iovance Biotherapeutics, se retirará tras su mandato actual

Iovance Biotherapeutics en la Conferencia de Barclays: Crecimiento estratégico y desafíos

Iovance Biotherapeutics en Conferencia Barclays: Crecimiento y Desafíos

Iovance Biotherapeutics at Barclays Conference: Strategic Growth and Challenges

What's Going On With Iovance Biotherapeutics Stock On Friday? - Iovance Biotherapeutics (NASDAQ:IOVA)

Las acciones de Iovance Biotherapeutics alcanzan un máximo de 52 semanas en 4,35 dólares